ISRCTN16838474已完成未知
Post-marketing observational study to follow-up patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and juvenile idiopathic arthritis who are treated with ExemptiaTM (Adalimumab).
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 149
研究概览
简要总结
2019 results in patients with rheumatoid arthritis in: https://www.ncbi.nlm.nih.gov/pubmed/31254222 (added 09/07/2019) 2019 results in patients with ankylosing spondylitis in: https://www.ncbi.nlm.nih.gov/pubmed/31777828 (added 02/12/2019)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. =2 years up to 75 years old
- •2. Diagnosis as per current guidelines published by ACR/EULAR/CASPAR/ILAR guidelines of:
- •2.1. Rheumatoid Arthritis
- •2.2. Ankylosing Spondylitis
- •2.3. Psoriatic arthritis
- •2.4. Juvenile Idiopathic Arthritis (JIA)
- •3. Treatment with ExemptiaTM (Adalimumab)
- •4. Subjects and/or their parent/ legal guardian were willing to be contacted in the future by study staff.
排除标准
- •1. Subjects receiving Adalimumab other than ExemptiaTM (Adalimumab)
- •2. Any contraindication for ExemptiaTM (Adalimumab) or concomitant drug like CNS and myeloid disorders according to Prescribing Information
研究者
相似试验
已完成
不适用
A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )Rheumatoid ArthritisAnkylosing SpondylitisPsoriatic ArthritisNCT01078558AbbVie (prior sponsor, Abbott)5,940
已完成
不适用
An Observational Study to Evaluate Impact of CRP-Level on Real World Effectiveness of Upadacitinib as Monotherapy or in Combination With MTX in Adult Participants With Rheumatoid ArthritisRheumatoid Arthritis (RA)NCT04267536AbbVie534
已完成
不适用
Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical PracticeRheumatoid ArthritisCrohn´s DiseaseUlcerative ColitisPsoriatic ArthritisPlaque PsoriasisAnkylosing SpondylitisNCT01768858AbbVie96
已完成
不适用
A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250)Rheumatoid ArthritisNCT00705289Merck Sharp & Dohme LLC728
已完成
不适用
A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic ArthritisRheumatoid Arthritis (RA)Atopic Dermatitis (AD)Ankylosing Spondylitis (AS)Psoriatic Arthritis (PsA)NCT04541810AbbVie2,369